Atraumatic Trochar Hormone Pellet Placement Techniques

Atraumatic Trochar Hormone Pellet Wellness and Care

Abstract

In this educational post, I guide you through a modern, first-person roadmap to bioidentical hormone pellet therapy, the atraumatic two-piece trochar technique for safer pellet placement, and how cardiac output shapes pellet duration and symptom trajectories. I explain women’s health decision points across birth control, perimenopause, postmenopause, hysterectomy, and PCOS; clarify the impact of testosterone on fertility and spermatogenesis; and share why skin physiology (including folliculitis) is tightly coupled to endocrine, gut, and autonomic dynamics. Throughout, I integrate chiropractic care into a functional medicine framework to optimize neuromusculoskeletal alignment, autonomic balance, lymphatic flow, and movement—so hormones can safely and effectively express their benefits.

My Integrative First Principles: Aligning Hormones, Heart, Movement, and Mind

As a clinician trained in both chiropractic and advanced nursing practice, I approach hormone care by harmonizing the endocrine, cardiovascular, neuromuscular, and neurocognitive systems. My goals are simple and patient-centered: restore energy, strength, sleep, mood, and sexual health, and reduce pain by matching physiology with evidence-based strategies.

• We start by clarifying goals: relief of fatigue, cognitive fog, low libido, mood shifts, sleep disruption, and musculoskeletal pain.
• We measure baseline physiology and labs to calibrate bioidentical hormone pellets and complementary therapies.
• We place pellets using an atraumatic lay-down trochar technique to minimize tissue trauma and improve comfort.
• We integrate chiropractic care, targeted rehab, and lifestyle protocols to unlock mechanical efficiency and autonomic balance.
• We track outcomes—cardiac output, body composition, HRV, strength markers, and validated symptom scales—to tailor timing and dosing (Joyner & Coyle, 2008; Shibata & Levine, 2013).

Why pellets? Bioidentical pellets provide steady tissue levels with fewer daily adherence barriers and typically lower hepatic impact than oral routes, supporting musculoskeletal remodeling, mitochondrial function, and cognitive performance when used judiciously and monitored (Santoro et al., 2016).

Why Atraumatic Trochar Technique Improves Outcomes

Older cut-and-plunge systems relied on a sharp cutting tip and forceful plunging that increased micro-tears, shear forces, and exudate. I use a two-piece trochar with an internal conical tip designed to atraumatically spread tissue and lay down pellets rather than plunge. The physiology behind this matters:

• Conical spreading protects microvasculature and the extracellular matrix, preserving orderly fibroblast migration and collagen deposition (Gurtner et al., 2008; Eming et al., 2014).
• Reduced cutting lowers immediate pro-inflammatory cytokine release (IL-1β, TNF-α), vasodilation, and fluid escape, thereby diminishing seromas and pain flares (Eming et al., 2014).
• Lower tissue trauma improves lymphatic clearance, limiting nociceptor sensitization and chronic tenderness.

In my clinic, switching to the lay-down method consistently reduces polyfluid drainage, maceration, and the need for dressing changes. Patients report cleaner insertions and faster functional recovery, consistent with evidence of reduced procedural trauma and biofilm risk (Percival & Suleman, 2015; Wolcott et al., 2010). Clinical observations at WellnessDoctorRX and in my professional updates support these superior healing trajectories (WellnessDoctorRX.com; LinkedIn.com/in/dralexjimenez).

Visualizing Technique and Anatomical Precision

I teach the 45-degree lay-down approach using clear ballistic gel to show how the trochar navigates the subcutaneous plane. The gel demonstrates how pellets settle without a pressure spike when the inner conical piece anchors and the outer cannula retracts.

• The 45-degree track avoids overly superficial dermal irritation and overly deep fascial pressure.
• Tactile feedback—feeling the slight transition at superficial fascia—confirms correct depth in fatty tissue.

For female placement, I prefer the upper outer gluteal region within the tan line—deep in subcutaneous fat, away from friction-prone IT band and pressure-heavy coccyx areas. Fat provides a stable depot with predictable kinetics and reduced mechanical stress; lateral IT band zones and proximity to the coccyx tend to increase friction, prostaglandin signaling, sweat-related irritation, and microbial overgrowth (Zava et al., 2018).

My favorite precision method is the needle landmark technique: place the lidocaine needle tip where pellets should land, lay the needle back, mark at the hub, and incise there. This aligns the tract and trochar length, so pellets land exactly in the intended depot and avoid lateral drift toward the IT band or medial drift toward the coccyx.

Skin Preparation, Anesthetic Physics, and Two-Piece Trochar Steps

I prep the skin with chlorhexidine-alcohol due to its superior antimicrobial activity and residual activity compared to alcohol alone, thereby reducing the risk of infection during minor procedures (Darouiche et al., 2010). Clean gloves, sterile instruments, and a focused field are non-negotiable.

• I raise a lidocaine wheal like a TB test and bathe the entire tract on the way in and out along a 45-degree path. Lidocaine blocks voltage-gated sodium channels in nociceptive fibers, delivering comfort while confirming the correct subcutaneous plane by blanching and reducing dermal irritation (Scholz & Woolf, 2002).
• With the skin tensioned, I make a small 1-cm incision using a number 11 blade and gently seat the trochar beneath the superficial fascia.
• I load pellets with sterile forceps, place a small cup beneath the opening to catch any drops, then anchor the pellets by holding the inner conical piece with my thumb.
• I retract the outer cannula first—feeling the click or re-seat—and then withdraw both together to lay down pellets atraumatically.

This anchor-and-lay approach reduces shearing, pressure spikes, and local edema—key reasons why patients in my practice report less soreness and a quicker return to daily activities.

Evidence-Based Wound Closure and Post-Care

A common mistake is using steri-strips as covers; they are functional butterfly sutures. I anchor one side, approximate the edges by pulling across, and let the steri-strips remain for at least 3 days or until they fall off naturally. Longer, proper approximation improves orderly collagen deposition and may reduce scarring (Gantwerker & Hom, 2011).

• I apply a pressure bandage with folded gauze and secure it with a T-pattern of tape to avoid inadvertently pulling off the steri-strips during removal.
• I counsel patients to avoid hot tubs, tub baths, or swimming for three days to reduce maceration and microbial exposure. Heat and immersion increase vasodilation and transudation, thereby increasing the risk of softening the keratin barrier and separating wound edges (Leaper et al., 2015).
• I advise minimizing excessive gluteal flexion or jarring activity for 72 hours to protect the early fibrin architecture, prevent pellet migration, and support granulation tissue.

Clinical observation: with proper closure and activity guidance, tenderness resolves quickly, and the incision remains clean—dramatically lowering call-backs for post-procedure discomfort.

Cardiac Output: The Metabolic Clock that Influences Pellet Duration

Patients quickly ask how long pellets will last. I explain cardiac output (CO)—stroke volume × heart rate—as the metabolic clock that determines hormone delivery and tissue uptake. Higher CO, with frequent training and dense capillary beds, accelerates distribution, receptor cycling, and utilization; pellet duration can shorten to 2–3 months in high-output individuals, whereas moderate-output individuals yield 3–4 months (Joyner & Coyle, 2008; Shibata & Levine, 2013).

• We track HRV, resting HR, blood pressure, VO2 surrogates, body composition, and symptom scales to personalize timing.
• Athletes often report earlier returns of subtle symptoms—energy dips, sleep fragmentation, libido changes—as markers that re-pelleting is due.

The physiology is straightforward: blood flow delivers hormones to tissues; muscle perfusion and mitochondrial efficiency shape utilization; and activity modulates hormonal receptor sensitivity. Monitoring these markers makes pellet timing proactive rather than reactive in my clinic.

Why Hormones Matter: Muscle, Brain, Intimacy, and Pain Relief

Balanced testosterone, estradiol, progesterone, and thyroid hormones act as master regulators across muscle, brain, and vascular systems:

• They stimulate muscle protein synthesis, satellite cell activation, and neuromuscular junction efficiency, improving strength and motor unit recruitment.
• They influence dopamine and serotonin pathways, elevating mood, drive, attention, and cognitive throughput (Gale & Harris, 2010; Schiller et al., 2016).
• They modulate endothelial function and vascular tone, shaping perfusion, recovery, and fatigue dynamics.

Women with low testosterone often experience improved libido, lean mass, and energy with evidence-based correction, alongside estradiol/progesterone support for sleep and stress resilience (Islam et al., 2019). Men see improvements in strength, fat loss, insulin sensitivity, and mood when testosterone is optimized through monitoring (Corona et al., 2014). As musculoskeletal pain recedes and mechanics improve, intimacy and social engagement rise—outcomes my patients frequently share, documented on WellnessDoctorRX and my LinkedIn.

Integrative Chiropractic Care: Making Hormones Work Better

Hormones cannot fully express their benefits if joints are hypomobile, muscles are inhibited, or patterns are dysfunctional. My integrative chiropractic care focuses on:

• Spinal adjustments to restore segmental motion and reduce central sensitization.
• Soft-tissue mobilization to free fascia, improve perfusion, and lower tone and trigger points (Schleip et al., 2012).
• Neuromuscular re-education to normalize motor patterns and stabilize the core.
• Breathing and thoracic mobility to improve diaphragmatic function, vagal tone, and oxygenation—supporting sleep, autonomic balance, and endocrine rhythms (Thayer & Lane, 2009).
• Lymphatic support and ergonomic coaching to minimize local pressure and shear near the insertion site.
• Training integration with progressive loading that stimulates collagen remodeling and sarcomere addition.

Clinically, pairing pellets with integrative chiropractic accelerates real-world outcomes: faster waist reduction, better gait mechanics, lower pain scores, and more consistent training. These observations are reflected in my published clinical insights (WellnessDoctorRX.com; LinkedIn.com/in/dralexjimenez).

Women’s Health Across the Lifespan: Birth Control, PMDD, Progesterone Timing, Hysterectomy, Postmenopause

I always begin with the question: Do you want children, and when? This defines our ethical and physiological pathway. In men, exogenous testosterone suppresses GnRH, LH, and FSH, lowering intratesticular testosterone and spermatogenesis. If family-building is planned within 12–18 months, I avoid testosterone and consider fertility-preserving alternatives, collaborating with urology/endocrinology (Hsieh et al., 2013; Patel et al., 2019; Wang et al., 2019).

• For women on combined oral contraceptives, we clarify goals—contraception, skin, bleed control, mood—and tailor transitions if moving toward bioidentical hormone support. We balance thromboembolic risks, migraine history, and blood pressure.

For PMDD, intermittent luteal-phase SSRIs can provide rapid symptom relief by modulating serotonergic mechanisms amid fluctuations in progesterone and neurosteroids; bioidentical progesterone supports GABAergic tone and sleep, reducing abrupt drops that trigger anxiety and irritability (Epperson et al., 2012; Pearlstein, 2020; Schwartz et al., 2016).

Progesterone timing in perimenopause and menopause is central. It stabilizes the endometrium; controlled withdrawal induces safe shedding when needed, preventing prolonged unopposed estrogen exposure. We use ultrasound to assess endometrial thickness when indicated and adjust dosing for symptom relief without oversedation (Stuenkel et al., 2015; NAMS, 2023).

After hysterectomy, ovarian status dictates therapy. With ovarian conservation, hormonal cycling persists without menses; with oophorectomy, estrogen and progesterone levels drop precipitously—raising vasomotor symptoms, bone loss, and cardiometabolic risk—thereby making timely, individualized menopausal hormone therapy protective (NAMS, 2023; Maki & Kornstein, 2017). In clear postmenopause (12 months without menses), hormone patterns stabilize, allowing precise titration of estradiol and progesterone (if uterus is present), with consideration of low-dose testosterone for libido and energy in select cases.

PCOS: Insulin Resistance, Hyperandrogenism, and Safe Strategies

PCOS spans hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology, often with insulin resistance and chronic inflammation (Azziz et al., 2016; Teede et al., 2018). Excess testosterone drives hirsutism, acne, androgenic alopecia, and central adiposity.

• I diagnose using Rotterdam criteria and assess fasting glucose/insulin, HOMA-IR, lipids, liver enzymes, and select endocrine panels.
• I prioritize metformin for insulin sensitivity and ovulatory restoration, with counseling that pregnancy can occur as cycles normalize (Lord et al., 2003; Teede et al., 2018).
• I address anti-androgen strategies (spironolactone with contraception) and combined OCPs for ovarian androgen reduction while tailoring lifestyle—resistance training, Mediterranean-style nutrition, sleep, and stress care.
• I avoid exogenous testosterone in PCOS unless tightly justified and monitored.

Integrative chiropractic helps patients move without pain, improving skeletal muscle glucose uptake and emotional stability—directly countering the drivers of PCOS.

Testosterone Therapy: Pellets vs. Injections, Fertility, and Safety Monitoring

Men often ask about testicular size and fertility. Any exogenous testosterone suppresses gonadotropins and reduces intratesticular testosterone, lowering sperm production during therapy. Injections can cause supra-physiologic peaks, more aggressive suppression, and sometimes visible testicular atrophy; pellets provide steadier levels with fewer peaks and troughs but still suppress LH/FSH. Recovery of spermatogenesis typically occurs within months after discontinuation, but timelines vary by dose and duration (Patel et al., 2019; Wang et al., 2019).

I monitor comprehensive labs—CBC, CMP, lipids, HbA1c, thyroid, sex hormones, SHBG, estradiol (individuals), progesterone (women), and DHT (case-by-case)—alongside body composition and cardiovascular metrics. I align protocols with Endocrine Society guidance to mitigate risks such as erythrocytosis, PSA changes, and lipid shifts, while tracking patient-reported outcomes (Davis et al., 2015; Corona et al., 2014).

Skin Health, Folliculitis, and the Gut–Skin–Hormone Axis

The skin is a neuroendocrine-immune organ. Androgens increase sebum production and modulate follicular keratinization, predisposing to acneiform eruptions and folliculitis; estrogens support barrier function; insulin/IGF-1 signaling from high-glycemic diets can exacerbate sebaceous activity and inflammation (Thiboutot et al., 2004; Smith et al., 2009; Rzepecki et al., 2019).

I assess hormones, insulin resistance, nutrient status, microbiome factors, sweat and occlusion, and training environment. I use a stepwise algorithm:

• Topical care: benzoyl peroxide wash for antimicrobial action, salicylic acid for keratolysis, and retinoids for normalized keratinization.
• Culture-guided antibiotics for bacterial folliculitis; ketoconazole-based washes for suspected Malassezia involvement.
• Nutritional shifts: low-glycemic plans, adequate protein, omega-3s, polyphenols, fiber; targeted micronutrients like zinc and vitamin D when indicated.
• Gut support with probiotics and barrier aids; elimination-reintroduction for dietary triggers.
• Integrative chiropractic to improve thoracic mobility, vagal tone, lymphatic flow, and autonomic balance, which reduces systemic inflammatory load.

When oncology-related concerns exist (e.g., hormone-responsive cancers or complex melanoma cases), I avoid exogenous hormones without specialist clearance, prioritizing safety through coordinated care (NCCN Guidelines; Basaria, 2010).

Metabolic Therapies, Training Integration, and Post-Procedure Guidance

Better metabolic control improves endocrine and skin outcomes. Modern standards incorporate GLP-1 receptor agonists and SGLT2 inhibitors for type 2 diabetes and cardiometabolic risk, given their strong cardiovascular and renal benefits beyond glycemic control (ADA, 2024; Zelniker et al., 2019). While not dermatologic therapies, reducing insulin and systemic inflammation frequently stabilizes acne and folliculitis profiles.

After pellet insertion, I recommend:

• Light walking the same day; avoid deep hip flexion loading, sprinting, or heavy gluteal work for 48–72 hours.
• Showering is fine; avoid soaking for 3 days to protect the integrity of the closure.
• Expect mild, transient swelling or tenderness; most patients notice benefits by days 7–10 as receptor occupancy and transcriptional changes build (Schiller et al., 2016).

As hormones begin to work, I leverage a training window that includes isometric core stability, gluteal activation, hip-hinge patterning, progressive resistance with controlled tempo, and aerobic base-building to sustainably elevate cardiac output. This coupling of mechanical loading and hormonal signaling produces durable gains and pain resilience.

Safety, Monitoring, and Avoiding Polypharmacy

Patients rightly worry about medication burden. Chronic high-dose NSAIDs carry renal and cardiovascular risks; benzodiazepines pose dependence concerns (Rothwell et al., 2011; Lader, 2011). My approach replaces symptom suppression with health creation: alignment, progressive loading, sleep, stress regulation, anti-inflammatory nutrition, and judicious hormones as indicated.

• I screen for contraindications (uncontrolled cardiovascular disease, active hormone-sensitive cancer, significant hematologic or hepatic risks).
• I obtain specialty clearance when needed and document shared decision-making and guideline references.
• I tailor male and female protocols with transparent lab tracking and outcome measures, ensuring doses remain the lowest effective and reversible when necessary.

In complex cases, telehealth enhances continuity while we maintain documentation and adhere to best practices, aligning with modern care models (Keesara et al., 2020).

Clinical Observations and Real-World Outcomes

From years of practice and community engagement:

• Patients who combine optimized cardiac output with structured strength training exhibit stronger pellet responses—better body composition, mood, motivation, and performance.
• Pairing pellets with integrative chiropractic and functional rehabilitation improves gait, lowers pain scores, and enables consistent training that extends the benefits of pellets.
• In women, balancing estradiol and progesterone with targeted testosterone often yields improved sleep, libido, and cognitive clarity.
• In PCOS, mechanical pain reduction and autonomic stabilization make insulin-sensitizing strategies more effective—often reducing medication needs over time.
• Skin conditions like folliculitis stabilize with low-glycemic nutrition, microbiome-aware hygiene, breathable fabrics, structured recovery, and thoracic mobility that supports lymphatic flow.

Conclusion: Atraumatic Precision, Cardio-Metabolic Insight, and Chiropractic Integration

Modern bioidentical hormone pellets, placed with a two-piece conical-tip trochar using an atraumatic lay-down method, reduce tissue trauma and improve comfort. Understanding cardiac output lets us tailor pellet timing; aligning endocrine therapies with integrative chiropractic care—spinal adjustments, soft-tissue mobilization, neuromuscular re-education, breathing mechanics, lymphatic support, and progressive loading—ensures hormones can fully express their benefits.

Across women’s health decision points, men’s fertility considerations, PCOS metabolic drivers, and skin physiology, the lesson is consistent: when we respect physiology, apply evidence-based protocols, and strengthen mechanical and autonomic foundations, outcomes become safer, more predictable, and deeply meaningful. This integrated model reduces polypharmacy, supports longevity, and helps patients move, think, sleep, and connect better—day by day, cycle by cycle.

References

• Chlorhexidine–Alcohol versus Povidone–Iodine for Surgical-Site Antisepsis (Darouiche, R. O., Wall, M. J., Jr., Itani, K. M. F., et al., 2010). New England Journal of Medicine, 362(1), 18–26. https://doi.org/10.1056/NEJMoa0810988
• Wound Repair and Regeneration: Mechanisms, Signaling, and Translation (Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T., 2008). Science, 324(5935), 585–589. https://doi.org/10.1126/science.1141731
• Inflammation in Wound Repair: Molecular and Cellular Mechanisms (Eming, S. A., Martin, P., & Tomic-Canic, M., 2014). Journal of Molecular Medicine, 92, 341–351. https://doi.org/10.1007/s00109-014-1218-1
• Biofilms and Wound Healing: A Review of the Evidence (Percival, S. L., & Suleman, L., 2015). International Wound Journal, 12(4), 398–405. https://doi.org/10.1111/iwj.12283
• Chronic Wound Biofilm Control: Advances in Understanding and Treatment (Wolcott, R. D., Rhoads, D. D., & Dowd, S. E., 2010). Clinical Microbiology Reviews, 23(3), 407–422. https://doi.org/10.1128/CMR.00032-09
• Mechanisms of Pain: From Nociception to Neuropathic Pain (Scholz, J., & Woolf, C. J., 2002). Nature Reviews Neuroscience, 3(9), 701–714. https://doi.org/10.1038/nrn0893
• Fascia: The Tensional Network of the Human Body (Schleip, R., Findley, T. W., Chaitow, L., & Huijing, P. A., 2012). Elsevier.
• Cardiorespiratory Fitness and the Integration of Muscle and Heart Function (Joyner, M. J., & Coyle, E. F., 2008). Journal of Applied Physiology, 104(1), 276–288. https://doi.org/10.1152/japplphysiol.01028.2007
• Orthostatic Intolerance and the Mechanisms of Cardiac Output Regulation (Shibata, S., & Levine, B. D., 2013). Journal of Applied Physiology, 115(8), 1209–1215. https://doi.org/10.1152/japplphysiol.00540.2013
• Bioidentical Hormone Therapy and Clinical Outcomes: Current Evidence (Santoro, N., et al., 2016). Menopause, 23(9), 1048–1055. https://doi.org/10.1097/GME.0000000000000719
• Estradiol, Progesterone, and Cognitive-Affective Function in Women (Islam, M. R., et al., 2019). Frontiers in Neuroscience, 13, 546. https://doi.org/10.3389/fnins.2019.00546
• Testosterone Therapy in Men: Metabolic and Cardiovascular Considerations (Corona, G., et al., 2014). The Journal of Clinical Endocrinology & Metabolism, 99(6), 2349–2358. https://doi.org/10.1210/jc.2013-4023
• Hormones and Synaptic Plasticity: Translational Perspectives (Schiller, C. E., et al., 2016). Cerebral Cortex, 26(11), 4310–4322. https://doi.org/10.1093/cercor/bhv165
• Basic Principles of Wound Management (Leaper, D., Harding, K., & Sibbald, R., 2015). Wiley-Blackwell.
• Polycystic Ovary Syndrome (Azziz, R., et al., 2016). Nature Reviews Disease Primers, 2, 16057. https://doi.org/10.1038/nrdp.2016.57
• Recommendations from the International Evidence-Based Guideline for PCOS (Teede, H., et al., 2018). Human Reproduction, 33(9), 1602–1618. https://doi.org/10.1093/humrep/dey256
• Metformin in Polycystic Ovary Syndrome: Systematic Review and Meta-analysis (Lord, J., Flight, I. H., & Norman, R. J., 2003). BMJ, 327(7421), 951–953. https://doi.org/10.1136/bmj.327.7421.951
• Testosterone Is a Contraceptive and Should Not Be Used in Men Who Desire Fertility (Patel, A. S., Leong, J. Y., Ramos, L., & Ramasamy, R., 2019). World Journal of Men’s Health, 37(1), 45–54. https://doi.org/10.5534/wjmh.180036
• Concomitant Intramuscular Testosterone and hCG Therapy Maintains Spermatogenesis (Hsieh, T. C., et al., 2013). Andrology, 1(5), 800–806. https://doi.org/10.1111/j.2047-2927.2013.00125.x
• Investigation, Treatment and Monitoring of Late-Onset Hypogonadism (Wang, C., Swerdloff, R. S., & Nieschlag, E., 2019). The Lancet Diabetes & Endocrinology, 7(1), 65–76. https://doi.org/10.1016/S2213-8587(18)30362-5
• Premenstrual Dysphoric Disorder: Evidence-Based Treatment (Epperson, C. N., Steiner, M., & Hartlage, S. A., 2012). Journal of Psychiatric Practice, 18(5), 295–306. https://doi.org/10.1097/01.pra.0000416014.61964.1f
• Premenstrual Dysphoric Disorder: Recognition and Treatment (Pearlstein, T., 2020). CNS Drugs, 34(10), 995–1007. https://doi.org/10.1007/s40263-020-00755-1
• Treatment of Symptoms of the Menopause: An Endocrine Society Guideline (Stuenkel, C. A., et al., 2015). Journal of Clinical Endocrinology & Metabolism, 100(11), 3975–4011. https://doi.org/10.1210/jc.2015-2236
• The 2023 North American Menopause Society Hormone Therapy Position Statement (NAMS, 2023). Menopause, 30(9), 1107–1153. https://doi.org/10.1097/GME.0000000000002175
• Menopause and Mental Health (Maki, P. M., & Kornstein, S. G., 2017). JAMA, 317(13), 1351–1352. https://doi.org/10.1001/jama.2017.3135
• Human Skin Is a Steroidogenic Tissue: New Evidence (Thiboutot, D., Jabara, S., & McAllister, J., 2004). The Journal of Clinical Endocrinology & Metabolism, 89(2), 794–804. https://doi.org/10.1210/jc.2003-031789
• A Low-Glycemic-Load Diet Improves Symptoms in Acne Vulgaris (Smith, R. N., et al., 2009). American Journal of Clinical Nutrition, 86(1), 107–115. https://doi.org/10.1093/ajcn/86.1.107
• Hormonal Influences on Hair Follicles: Update and Review (Rzepecki, A. K., et al., 2019). Dermatologic Clinics, 37(3), 275–292. https://doi.org/10.1016/j.det.2019.03.008
• Claude Bernard and the Heart–Brain Connection: Autonomic Nervous System Dynamics, Health, and Disease (Thayer, J. F., & Lane, R. D., 2009). International Journal of Psychophysiology, 73(2), 91–99. https://doi.org/10.1016/j.ijpsycho.2008.08.001
• NSAIDs and Long-Term Risk: Vascular and Renal Considerations (Rothwell, P. M., et al., 2011). The Lancet, 377(9759), 131–138. https://doi.org/10.1016/S0140-6736(11)61110-1
• Benzodiazepines: Risks of Long-Term Use and Dependence (Lader, M., 2011). Advances in Psychiatric Treatment, 17(4), 287–296. https://doi.org/10.1192/apt.bp.109.007179
• Standards of Medical Care in Diabetes—2024 (American Diabetes Association, 2024). Diabetes Care, 47(Suppl. 1), S1–S4. https://doi.org/10.2337/dc24-Sint
• SGLT2 Inhibitors for Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Type 2 Diabetes (Zelniker, T. A., et al., 2019). The New England Journal of Medicine, 380(4), 221–232. https://doi.org/10.1056/NEJMoa1812389
• Covid-19 and Health Care’s Digital Revolution (Keesara, S., Jonas, A., & Schulman, K., 2020). The New England Journal of Medicine, 382(23), e82. https://doi.org/10.1056/NEJMp2003539
• NCCN Clinical Practice Guidelines in Oncology: Cutaneous Melanoma (NCCN, current version online).
• Guidelines of Care for the Management of Acne Vulgaris (Zaenglein, A. L., et al., 2016). Journal of the American Academy of Dermatology, 74(5), 945–973. https://doi.org/10.1016/j.jaad.2015.12.037